EquityFlow › Companies › EXO Biologics

EXO Biologics

Biotech · Liege, BE

Clinical-stage biotech harnessing exosomes.

Funding history

Date	Round	Amount
Apr 2024	Series A EXO Biologics, a Liege exosome biotech, raised up to EUR16M in Series A (EUR9M equity plus EUR7M subsidies).	$17.3M

Investors

NOSHAQ

Similar companies in Biotech

Imperagen Haga Bioscience Pixelgen Technologies Gallant Chai Discovery SNIPR Biome Cellbox Labs Scope Biosciences GenLumina Actithera NUCLIDIUM Anocca

Explore funding flow on EquityFlow →